Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 859 clinical trials
Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer

treatment trajectory. GI-HEP: Patients with tumors of the upper gastrointestinal or hepatobiliary tract, specifically tumors of the esophagus, gastro-esophageal junction, stomach, primary tumors of

primary tumor
liver metastasis
metastasis
primary cancer
cancer
  • 0 views
  • 24 Jan, 2021
Web-Based Family Outreach Program for Cancer Prevention in High-Risk Families

This trial develops a patient-driven self-navigated web-based family outreach program for cancer prevention in high-risk families. Creating the family outreach program may help to improve the way in which genetic test results are communicated within families and increase the number of at-risk relatives who become aware of their risks.

cancer
primary cancer
  • 0 views
  • 23 Jan, 2021
  • 2 locations
CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)

This study will collect data on Canadian cancer patients that have uncommon/rare changes in their tumours, such as alterations/rearrangements in the genetic material inside cells - known as deoxyribonucleic acid, or DNA, which acts as a map and gives directions to the cells on how to make other substances the …

cancer care
EGFR
BRAF
cancer diagnosis
cancer treatment
  • 1 views
  • 23 Jan, 2021
  • 1 location
Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA

Nucleix EpiCheck tests analyzes the methylation pattern in a panel of DNA methylation biomarkers and determines whether this pattern is consistent with cancer under test or with non-cancer tissue. This study is being performed as part of the development process of the Pan Cancer EpiCheck test which includes the identification …

cancer
primary cancer
  • 1 views
  • 23 Jan, 2021
  • 3 locations
Cardio-Oncology Registry

Cardio-oncology is an emerging field. Most of the data available have been issued from either retrospective analysis, industry data or pharmacovigilance data. These data sources include a number of bias. CONFUCIUS is a single tertiary centre prospective registry including all patients who have been referred for cardio-oncology assessemnt. The objectives …

cancer
primary cancer
  • 0 views
  • 25 Jan, 2021
  • 1 location
Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA)

CORIA is an observational cohort study of immunosuppressed populations who test positive for COVID-19. This includes people living with HIV, cancer, acquired immunodeficiency associated with other immunosuppressive therapy, primary immunodeficiency and recipients of a solid organ transplant. Participants will have routine clinical data collected with optional baseline collection and storage …

diarrhea
immunosuppressive agents
carcinoma
cough
myalgia
  • 0 views
  • 25 Jan, 2021
  • 11 locations
The C3I COVID-19 Project

This cohort study will obtain electronic health record (EHR) de-identified data from 21 health systems affiliated with the Cancer Center Cessation Initiative (C3I) network or health systems with large numbers of COVID-19 patients to explore whether smoking status, cancer history, and other risk factors among patients diagnosed with COVID-19 are …

cancer
primary cancer
  • 10 views
  • 28 Jan, 2021
  • 1 location
Onco-Geriatric Screening of Cancer Patients Age 70 or More

Older patients with cancer constitute a heterogeneous group with varying comorbidity; therefore, geriatric assessment with initial screening is recommended. The Geriatric 8 (G8) has been established as a promising screening tool. Currently, there are no guidelines for oncogeriatric screening in older cancer patients in Denmark. We hypothesize that by screening …

  • 0 views
  • 27 Jan, 2021
  • 1 location
Ruxolitinib in Myelofibrosis Patients in Lombardy Italy

Ematologica Lombarda) in Italy. Efficacy data, data related to infectious and vascular events, data related to second primary malignancies, data regarding disease progression/transformation, and molecular

ruxolitinib
essential thrombocythemia
stem cell transplantation
thrombocytosis
cancer
  • 50 views
  • 22 Jan, 2021
  • 7 locations
A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for Transplant

6 months' post treatment and a follow up period until 5 years after inclusion. During follow up the incidence of second primary malignancies (SPM) and overall survival will be assessed.

cancer
revlimid
lenalidomide
  • 170 views
  • 26 Jan, 2021
  • 162 locations